The Economic growth controversy /

Por Weintraub, Andrew., Schwartz, Eli., Aronson, J. Richard
Publicado em 1974

The Economic growth controversy /

Por Weintraub, Andrew., Schwartz, Eli., Aronson, J. Richard
Publicado em 1973

Can Clinical Predictive Models Identify Patients Who Should Not Receive TAVR? A Systematic Review

Por Wessler, Benjamin S., Weintraub, Andrew R., Udelson, James E., Kent, David M.
Publicado no Struct Heart (2020)

Safety and efficacy of transaxillary transcatheter aortic valve replacement using a current-generation balloon-expandable valve

Por Zhan, Yong, Toomey, Nicholas, Ortoleva, Jamel, Kawabori, Masashi, Weintraub, Andrew, Chen, Frederick Y.
Publicado no J Cardiothorac Surg (2020)

Bivalirudin is a Dual Inhibitor of Thrombin and Collagen-Dependent Platelet Activation in Patients Undergoing Percutaneous Coronary Intervention

Por Kimmelstiel, Carey, Zhang, Ping, Kapur, Navin K., Weintraub, Andrew, Krishnamurthy, Barath, Castaneda, Vilma, Covic, Lidija, Kuliopulos, Athan
Publicado em 2011

Chronic Conditions in Advanced Cardiac Disease: A Cluster Analysis of Transcatheter Aortic Valve Replacement (TAVR)-Treated Patients

Por Wessler, Benjamin S., Koethe, Benjamin C., Han, Paul K. J., Weintraub, Andrew R., Udelson, James E., Boyd, Cynthia M., Kent, David M.
Publicado no J Gen Intern Med (2020)

Enhanced potency of prasugrel on protease-activated receptors following bivalirudin treatment for PCI as compared to clopidogrel

Por Kimmelstiel, Carey, Stevenson, Ryan, Nguyen, Nga, Van Doren, Layla, Zhang, Ping, Perkins, James, Kapur, Navin K., Weintraub, Andrew, Castaneda, Vilma, Kuliopulos, Athan, Covic, Lidija
Publicado no Thromb Res (2019)